Delivery Order SPE2DE24D0013-SPE2D625F0STN

The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular diagnostic systems and associated reagents. The award carries no set-aside designation and is likely issued under one of Cepheid's existing indefinite delivery vehicle contracts with the Veterans Administration or Defense Health Agency, which provide the contracting mechanisms for such delivery orders.

Cepheid is an established federal contractor with significant experience supplying molecular diagnostic equipment and testing services across the Department of Defense and Veterans Affairs healthcare systems. The company's core offerings include diagnostic systems, molecular reagents, and maintenance services for detecting infectious diseases and clinical conditions. With multiple IDV contracts totaling over $35 million with the Veterans Integrated Service Networks, Cepheid maintains competitive positioning in federal procurement for molecular diagnostics, particularly for respiratory and infectious disease testing applications critical to military and veteran healthcare operations.